WallStreetZenWallStreetZen

NASDAQ: CVRX
Cvrx Inc Stock Forecast, Predictions & Price Target

Analyst price target for CVRX

Based on 3 analysts offering 12 month price targets for Cvrx Inc.
Min Forecast
$14.00-27.84%
Avg Forecast
$15.67-19.24%
Max Forecast
$18.00-7.22%

Should I buy or sell CVRX stock?

Based on 3 analysts offering ratings for Cvrx Inc.
Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CVRX stock forecasts and price targets.

CVRX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
JP Morgan
Top 18%
83
Strong BuyMaintains$18.00-7.22%2023-01-27
Piper Sandler
Bottom 7%
7
Strong BuyMaintains$14.00-27.84%2022-11-02
Craig-Hallum
Bottom 3%
3
BuyInitiates Coverage On$15.00-22.68%2022-07-18

1 of 1

Forecast return on equity

Is CVRX forecast to generate an efficient return?
Company
-75.9%
Industry
18.27%
Market
57.51%
CVRX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CVRX forecast to generate an efficient return on assets?
Company
-70.9%
Industry
12.73%
CVRX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CVRX earnings per share forecast

What is CVRX's earnings per share in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
-$2.04
Avg 2 year Forecast
-$2.00
Avg 3 year Forecast
-$4.36

CVRX revenue forecast

What is CVRX's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$39.8M+110.21%
Avg 2 year Forecast
$59.6M+214.52%
Avg 3 year Forecast
$99.7M+426.2%
CVRX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CVRX revenue growth forecast

How is CVRX forecast to perform vs Medical Devices companies and vs the US market?
Company
86.21%
Industry
7.6%
Market
11.01%
CVRX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CVRX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CVRX vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
CVRX$19.40$15.67-19.24%Strong Buy
RXST$13.91$16.67+19.82%Buy
APEN$9.94$9.75-1.91%Buy
AXGN$9.90$14.67+48.15%Strong Buy
EDAP$10.88$11.50+5.70%Strong Buy

Cvrx Stock Forecast FAQ

Is Cvrx Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: CVRX) stock is to Strong Buy CVRX stock.

Out of 3 analysts, 2 (66.67%) are recommending CVRX as a Strong Buy, 1 (33.33%) are recommending CVRX as a Buy, 0 (0%) are recommending CVRX as a Hold, 0 (0%) are recommending CVRX as a Sell, and 0 (0%) are recommending CVRX as a Strong Sell.

If you're new to stock investing, here's how to buy Cvrx stock.

What is CVRX's earnings growth forecast for 2023-2025?

(NASDAQ: CVRX) Cvrx's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 42.29%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 27.21%.

Cvrx's earnings in 2023 is -$41,462,000.On average, 3 Wall Street analysts forecast CVRX's earnings for 2023 to be -$41,991,693, with the lowest CVRX earnings forecast at -$59,076,548, and the highest CVRX earnings forecast at -$24,083,471. On average, 2 Wall Street analysts forecast CVRX's earnings for 2024 to be -$41,168,326, with the lowest CVRX earnings forecast at -$63,399,222, and the highest CVRX earnings forecast at -$18,937,430.

In 2025, CVRX is forecast to generate -$89,746,951 in earnings, with the lowest earnings forecast at -$89,746,951 and the highest earnings forecast at -$89,746,951.

What is CVRX's revenue growth forecast for 2023-2025?

(NASDAQ: CVRX) Cvrx's forecast annual revenue growth rate of 86.21% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.6%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 11.01%.

Cvrx's revenue in 2023 is $18,951,000.On average, 3 Wall Street analysts forecast CVRX's revenue for 2023 to be $819,990,717, with the lowest CVRX revenue forecast at $790,226,018, and the highest CVRX revenue forecast at $872,768,511. On average, 2 Wall Street analysts forecast CVRX's revenue for 2024 to be $1,226,919,036, with the lowest CVRX revenue forecast at $1,185,441,947, and the highest CVRX revenue forecast at $1,268,396,124.

In 2025, CVRX is forecast to generate $2,052,652,734 in revenue, with the lowest revenue forecast at $2,052,652,734 and the highest revenue forecast at $2,052,652,734.

What is CVRX's forecast return on assets (ROA) for 2023-2025?

(NASDAQ: CVRX) forecast ROA is -70.9%, which is lower than the forecast US Medical Devices industry average of 12.73%.

What is CVRX's Price Target?

According to 3 Wall Street analysts that have issued a 1 year CVRX price target, the average CVRX price target is $15.67, with the highest CVRX stock price forecast at $18.00 and the lowest CVRX stock price forecast at $14.00.

On average, Wall Street analysts predict that Cvrx's share price could fall to $15.67 by Jan 27, 2024. The average Cvrx stock price prediction forecasts a potential downside of 19.24% from the current CVRX share price of $19.40.

What is CVRX's Earnings Per Share (EPS) forecast for 2023-2025?

(NASDAQ: CVRX) Cvrx's current Earnings Per Share (EPS) is -$1.01. On average, analysts forecast that CVRX's EPS will be -$2.04 for 2023, with the lowest EPS forecast at -$2.87, and the highest EPS forecast at -$1.17. On average, analysts forecast that CVRX's EPS will be -$2.00 for 2024, with the lowest EPS forecast at -$3.08, and the highest EPS forecast at -$0.92. In 2025, CVRX's EPS is forecast to hit -$4.36 (min: -$4.36, max: -$4.36).

What is CVRX's forecast return on equity (ROE) for 2023-2025?

(NASDAQ: CVRX) forecast ROE is -75.9%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.